In Memoriam

In memoriam: Lucy Chang and Fred Bollum

ASBMB Today Staff
Jan. 15, 2024

Lucy Chang and Fred Bollum, personal and professional partners for more than four decades and longtime members of the American Society for Biochemistry and Molecular Biology, both died in the past year; Bollum on March 2 and Chang on Nov. 13.  Bollum was 95, and Chang was 81.

Frederick James Bollum was born June 14, 1927, in Ellsworth, Wisconsin, the son of Frederick Edward and Helen (Bucholtz) Bollum. He started college at the University of Minnesota as a zoology major and graduated in 1956 with a Ph.D. in physiological chemistry. He conducted a U.S. Public Health Service postdoctoral fellowship at the University of Wisconsin. He then worked at the Oak Ridge National Laboratory, as a biochemistry professor at the University of Kentucky Medical School, and as chair and professor of biochemistry at the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

Lucy Ming Shih Chang was born August 20, 1942, in China, to Timothy Y.N. Chang and Florence I.C. Chang. She earned a B.S. in chemistry at Case Western Reserve University in 1964 and a Ph.D. in biochemistry from Indiana University in 1968; she then pursued postdoctoral research at the University of Kentucky. She began her independent research career the University of Connecticut before serving as professor and department chair at USUHS.

Bollum joined the ASBMB in 1961, and Chang joined in 1974. Bollum was a member of the Journal of Biological Chemistry editorial board in the mid-1960s. During their joint research career, they conducted seminal work on DNA polymerases and discovered the mammalian terminal deoxynucleotidyl transferase, or TdT, a specialized DNA polymerase expressed in precancerous cells and acute leukemia and lymphoma cells.

PDB
Lucy Chang and Fred Bollum built a business around their discovery of the mammalian terminal deoxynucleotidyl transferase, or TdT.

In 1982, Bollum and Chang founded Supertechs, Inc., a biotechnology firm in Rockville, Maryland, specializing in diagnostics for leukemia and apoptosis research. They worked to produce and market monospecific antibodies to TdT. Certain cancerous cells express abnormal concentrations of TdT, making high levels of TdT-positive cells in blood and bone marrow a symptom of disease. Together, Bollum and Chang developed numerous patents related to TdT and other related enzymes.

Bollum’s many interests included music (clarinet and guitar), radio-controlled plane and boat models, astronomy, sculpture and cabinetry. Chang enjoyed knitting. They both liked to travel and spend time at their house on the Chesapeake Bay where Bollum kept an eye on the wildlife and the heavens with his collection of telescopes and binoculars.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

2025 PROLAB awardees announced
Marissa Locke Rottinghaus
Daniel N. Hebert (1962–2024)
Ineke Braakman, Maurizio Molinari, Reid Gilmore & Lila Gierasch

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.